Skip to content

4598.T

Delta-Fly Pharma,Inc.

グロース · 医薬品 · 医薬品 · JP

JPY 111.00
−9.02%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
R&D Expense
SG&A Expense
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses
Cost and Expenses
Operating Income (EBIT)(1.6B)(1.6B)(1.7B)(1.4B)(1.3B)
Non-Operating
Interest Income799.0K921.0K337.0K14.0K13.0K
Interest Expense
Net Interest Income
Other Non-Op Income/Expense(9.5M)(18.4M)(10.4M)(23.4M)(9.9M)
Non-Operating Income (excl Interest)(1.0M)33.0K11.0K2.0K32.0K
EBT (Pre-Tax Income)(1.7B)(1.6B)(1.7B)(1.4B)(1.3B)
Income Tax Expense2.5M2.5M2.5M2.5M3.0M
Bottom Line
Net Income(1.7B)(1.6B)(1.7B)(1.4B)(1.3B)
Earnings from Cont. Ops
Earnings from Discont. Ops
Bottom Line Net Income(1.7B)(1.6B)(1.7B)(1.4B)(1.3B)
Per Share
Basic EPS(¥162)(¥140)(¥196)(¥199)(¥235)
Diluted EPS(¥162)(¥140)
Revenue Per Share
Shares
Basic Shares Outstanding11.3M11.6M8.8M7.2M5.7M
Diluted Shares Outstanding
Profitability Metrics
EBITDA(886.5M)(1.6B)(1.7B)(1.4B)(1.3B)
D&A1.5M1.4M1.6M1.5M1.6M
EBIT(1.6B)(1.6B)(1.7B)(1.4B)(1.3B)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026